Feb 28 (Reuters) - Amarin Corporation PLC AMRN.O :
- AMARIN AND CSL SEQIRUS ANNOUNCE EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENT TO COMMERCIALIZE VAZKEPA (ICOSAPENT ETHYL) IN AUSTRALIA AND NEW ZEALAND
- UNDER TERMS OF AGREEMENT, CSL SEQIRUS WILL IN-LICENSE VAZKEPA FROM AMARIN
- CSL SEQIRUS TO BE RESPONSIBLE FOR MARKET ACCESS, REIMBURSEMENT EFFORTS, DISTRIBUTION, FOR VAZKEPA ACROSS AUSTRALIA, NEW ZEALAND
- AMARIN WILL RECEIVE AN UPFRONT PAYMENT AND BE ELIGIBLE FOR EVENT-RELATED MILESTONE PAYMENTS OF UP TO APPROXIMATELY $8 MILLION
- AMARIN WILL RECEIVE ADDITIONAL PRODUCT-RELATED MILESTONE PAYMENTS OF UP TO APPROXIMATELY $4 MILLION
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$265.50 |
Change
1.550(0.59%) |
Mkt cap ! $128.5B | |||
| Open | High | Low | Value | Volume |
| $264.45 | $265.88 | $259.33 | $230.1M | 870.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 27 | $265.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $265.80 | 79 | 1 |
View Market Depth
| Last trade - 16.12pm 23/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |